Repligen (RGEN) director granted RSUs and stock options as compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Repligen Corp director Karen A. Dawes received equity compensation consisting of restricted stock units and stock options. She was granted 995 restricted stock units, each representing one share of common stock, which vest on the earlier of May 14, 2027 or the next annual shareholder meeting. She also received options for 2,239 shares of common stock at an exercise price of $103.38 per share, expiring on May 14, 2036. Following these awards, she directly holds 92,816 common shares. These are compensation grants, not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
DAWES KAREN A
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,239 | $0.00 | -- |
| Grant/Award | Common Stock | 995 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,239 shares (Direct, null);
Common Stock — 92,816 shares (Direct, null)
Footnotes (1)
- Ms. Dawes was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.
Key Figures
Restricted stock units granted: 995 units
Stock options granted: 2,239 options
Option exercise price: $103.38 per share
+3 more
6 metrics
Restricted stock units granted
995 units
Equity award to director on May 14, 2026
Stock options granted
2,239 options
Right to buy Repligen common stock
Option exercise price
$103.38 per share
Conversion or exercise price for stock options
Option expiration date
May 14, 2036
Final expiration of granted options
Shares held after transaction
92,816 shares
Total common shares directly owned after awards
Vesting date trigger
Earlier of May 14, 2027 or next annual meeting
Vesting condition for RSUs and options
Key Terms
restricted stock units, Stock Option (Right to Buy), contingent right, vest, +1 more
5 terms
restricted stock units financial
"Ms. Dawes was awarded 995 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
vest financial
"The restricted stock units vest on the earlier of May 14, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did Repligen (RGEN) director Karen Dawes receive in this Form 4 filing?
Director Karen Dawes received equity compensation awards, not open-market trades. She was granted 995 restricted stock units and stock options for 2,239 shares, both tied to Repligen common stock, as part of her director compensation package.
How many Repligen (RGEN) restricted stock units were granted to Karen Dawes?
Karen Dawes was granted 995 restricted stock units. Each unit represents a contingent right to receive one share of Repligen common stock, subject to vesting conditions tied to time and the company’s next annual meeting of shareholders.
When do Karen Dawes’ Repligen (RGEN) restricted stock units and options vest?
Both the 995 restricted stock units and the 2,239 stock options vest in full on the earlier of May 14, 2027, one year from the grant date, or the date of Repligen’s next annual meeting of shareholders, whichever occurs first, according to the filing footnotes.
What are the key terms of Karen Dawes’ Repligen (RGEN) stock options?
Karen Dawes received stock options for 2,239 shares of Repligen common stock with an exercise price of $103.38 per share. These options vest on a time-based schedule and expire on May 14, 2036, if not exercised before that date.